Analysis of the dynamics of Neisseria gonorrhоeaе resistance to antimicrobial drugs in the Russian Federation for the period 2005–2021
- Authors: Shagabieva J.Z.1, Nosov N.Y.1, Shpilevaya M.V.1, Deryabin D.G.1, Obraztsova O.A.1, Nikonorova E.R.2, Solomka V.S.1, Kubanov A.A.1
-
Affiliations:
- Federal State Research Center of Dermatovenereology and Cosmetology
- All-Russian Research Institute of Medicinal and Aromatic Plants
- Issue: Vol 99, No 3 (2023)
- Pages: 53-62
- Section: ORIGINAL STUDIES
- URL: https://journals.rcsi.science/0042-4609/article/view/131374
- DOI: https://doi.org/10.25208/vdv1410
- ID: 131374
Cite item
Full Text
Abstract
Background. Neisseria gonorrhoeae can rapidly develop resistance to antimicrobial agents due to innate mechanisms for the acquisition of antimicrobial resistance genes. Because of the rapid formation of resistance mechanisms of N. gonorrhoeae to the antimicrobial agents used in gonococcal therapy, the risk of incurable forms of the disease is high. The purpose of the study is to to summarize the results of RU-GASP over a 16-year period and assess the trends of N. gonorrhoeae resistance to antimicrobials used in the regimens of antibiotic therapy of gonococcal infection in Russia.
Materials and methods. Study Objective. The study included 5356 isolates of N. gonorrhoeae received from January 2005 to December 2021 in State Scientific Center of Dermatovenerology and Cosmetology, Moscow of the Ministry of Health of Russia under the RU-GASP program from specialized medical organizations of dermatovenerological profile of 37 subjects of the Russian Federation. Primary identification of N. gonorrhoeae was performed using bacterioscopic and bacteriological methods. The cultures identified as N. gonorrhoeae were frozen in a cryogenic medium and transported to SSCDC. Received cultures were verified by biochemical criteria on a VITEK 2 Compact analyzer. For cultures identified as N. gonorrhoeae with less than 99% probability, a time-of-flight ionization mass spectrometer MALDI Microflex (Bruker Daltonics GmbH, Germany) was used for mass spectrometric analysis.
Antimicrobial susceptibility testing. Sensitivity testing of N. gonorrhoeae to six antimicrobials — penicillin, spectinomycin, ceftriaxone, tetracycline, azithromycin and ciprofloxacin was performed by serial dilution in agar with determination of minimum suppressive concentrations (MSC, mg/L). N. gonorrhoeae sensitivity to antibacterial agents was evaluated according to EUCAST criteria (The European Committee on Antimicrobial Susceptibility Testing, 2022, http://www.eucast.org).
Results. The study showed the absence of significant changes in the ratio of sensitive and resistant to the action of antimicrobial drugs strains of N. gonorrhoeae that is a consequence of the effectiveness of the RU-GASP program, which allowed to exclude in time from therapeutic use the drugs for which a high proportion of the identified resistant strains was observed.
Conclusion. Analysis of RU-GASP results over a 16-year period confirms the use of third-generation cephalosporins (Ceftriaxone, Cefixime) as the drugs of choice for therapy of gonococcal infection, and the aminocyclic antibiotic spectinomycin as an alternative drug. The continued evolution of the molecular mechanisms of antibiotic resistance of N. gonorrhoeae dictates the need to continue the RU-GASP program.
Full Text
##article.viewOnOriginalSite##About the authors
Julia Z. Shagabieva
Federal State Research Center of Dermatovenereology and Cosmetology
Author for correspondence.
Email: shagabieva1412@mail.ru
ORCID iD: 0000-0002-7595-0276
SPIN-code: 7270-5113
Cand. Sci. (Chem.)
Russian Federation, MoscowNikita Y. Nosov
Federal State Research Center of Dermatovenereology and Cosmetology
Email: nosovnj@mail.ru
ORCID iD: 0000-0002-3967-8359
SPIN-code: 8806-8539
Cand. Sci. (Biol.)
Russian Federation, MoscowMarina V. Shpilevaya
Federal State Research Center of Dermatovenereology and Cosmetology
Email: aniram1970@list.ru
ORCID iD: 0000-0002-9957-4009
SPIN-code: 6600-3311
Cand. Sci. (Biol.)
Russian Federation, MoscowDmitry G. Deryabin
Federal State Research Center of Dermatovenereology and Cosmetology
Email: dgderyabin@yandex.ru
ORCID iD: 0000-0002-2495-6694
SPIN-code: 8243-2537
MD, Dr. Sci. (Med.), Professor
Russian Federation, MoscowOlga A. Obraztsova
Federal State Research Center of Dermatovenereology and Cosmetology
Email: valeeva19@gmail.com
ORCID iD: 0000-0002-5728-2139
SPIN-code: 6355-4699
Cand. Sci. (Biol.)
Russian Federation, MoscowEvgenia R. Nikonorova
All-Russian Research Institute of Medicinal and Aromatic Plants
Email: gatiatulinaer@gmail.com
ORCID iD: 0000-0002-6360-2194
SPIN-code: 5392-5170
MD, Cand. Sci. (Med.)
Russian Federation, MoscowVictoria S. Solomka
Federal State Research Center of Dermatovenereology and Cosmetology
Email: solomka@cnikvi.ru
ORCID iD: 0000-0002-6841-8599
SPIN-code: 1486-3284
Dr. Sci. (Biol.)
Russian Federation, MoscowAlexey A. Kubanov
Federal State Research Center of Dermatovenereology and Cosmetology
Email: alex@cnikvi.ru
ORCID iD: 0000-0002-7625-0503
SPIN-code: 8771-4990
MD, Dr. Sci. (Med.), Professor, Academician of the Russian Academy of Sciences
Russian Federation, MoscowReferences
- Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al. Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting. PLoS One. 2015;10(12):e0143304. doi: 10.1371/journal.pone.0143304
- Ma KC, Mortimer TD, Hicks AL, Wheeler NE, Sánchez-Busó L, Golparian D, et al. Adaptation to the cervical environment is associated with increased antibiotic susceptibility in Neisseria gonorrhoeae. Nat Commun. 2020;11(1):4126. doi: 10.1038/s41467-020-17980-1
- Global health sector strategy on Sexually Transmitted Infections, 2016–2021. World Health Organization; 2016. https://www.who.int/publications/i/item/WHO-RHR-16.09 (4 April 2023)
- Cole MJ, Unemo M, Hoffmann S, Chisholm SA, Ison CA, van de Laar MJ. The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill. 2011;16(42):19995.
- Unemo M, Ison CA, Cole M, Spiteri G, van de Laar M, Khotenashvili L. Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European region, including the independent countries of the former Soviet Union. Sex Transm Infect. 2013;89(Suppl 4):iv42–iv46. doi: 10.1136/sextrans-2012-050909
- Kubanov A, Solomka V, Plakhova X, Chestkov A, Petrova N, Shaskolskiy B, et al. Summary and Trends of the Russian Gonococcal Antimicrobial Surveillance Programme, 2005 to 2016. J Clin Microbiol. 2019;57(6):e02024-18. doi: 10.1128/JCM.02024-18
- Warner PF, Zubrzycki LJ, Chila M. Polygenes and modifier genes for tetracycline and penicillin resistance in Neisseria gonorrhoeae. J Gen Microbiol. 1980;117(1):103–110. doi: 10.1099/00221287-117-1-103
- Лесная И. Н., Соломка В. С., Фриго Н. В., Кубанов А. А., Полевщикова С. А., Сидоренко С. В. Выбор препаратов для лечения гонококковой инфекции на основании результатов мониторинга антибиотикорезистентности N. gonorrhoeae. Вестник дерматологии и венерологии. 2010;(5):65–73 [Lesnaja IN, Solomka VS, Frigo NV, Kubanov AA, Polevshhikova SA, Sidorenko SV. Selection of drugs for treatment of gonococcal infection based on the results of the monitoring of N. gonorrhoeae antibiotic resistance. Vestnik dermatologii i venerologii. 2010;(5):65–73. (In Russ.)]
- Golparian D, Bazzo ML, Golfetto L, Gaspar PC, Schörner MA, Schwartz Benzaken A, et al. Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015–16. J Antimicrob Chemother. 2020;75(11):3163–3172. doi: 10.1093/jac/dkaa318
- Unemo M, Golparian D, Eyre DW. Antimicrobial resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea. Methods Mol Biol. 2019;1997:37–58. doi: 10.1007/978-1-4939-9496-0_3
- Азизова Р. А., Юнусова Ш. Э., Дадамухамедова Х. Э., Бобоев Х. Н., Раимкулов Р. С. Анафилактический шок — последствия цефалоспоринов. Science and innovation. 2022;1(8):373–378 [Azizova RA, Junusova ShJe, Dadamuhamedova HJe, Boboev HN, Raimkulov RS. Anaphilactic shock — consequences of cephalosporins. Science and innovation. 2022;1(8):373–378. (In Russ.)] doi: 10.5281/zenodo.739213
- Yaesoubi R, Cohen T, Hsu K, Gift TL, St Cyr SB, Salomon JA, et al. Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics. PLoS Comput Biol. 2022;18(2):e1009842. doi: 10.1371/journal.pcbi.1009842
- Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. World Health Organization; 2016. https://www.who.int/publications/i/item/9789241503501 (4 April 2023)
- Shaskolskiy B, Dementieva E, Kandinov I, Filippova M, Petrova N, Plakhova X, et al. Resistance of Neisseria gonorrhoeae isolates to beta-lactam antibiotics (benzylpenicillin and ceftriaxone) in Russia, 2015–2017. PLoS One. 2019;14(7):e0220339. doi: 10.1371/journal.pone.0220339
- Unemo M, Ross J, Serwin A, Gomberg M, Cusini M, Jensen JS. 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2020; 956462420949126. doi: 10.1177/0956462420949126
- Unemo M, Lahra MM, Escher M, Eremin S, Cole MJ, Galarza P, et al. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–2018: a retrospective observational study. Lancet Microbe. 2021;2(11):e627–e636. doi: 10.1016/S2666-5247(21)00171-3
- Кубанов А. А., Соломка В. С., Рахматулина М. Р., Дерябин Д. Г. Устойчивость Neisseria gonorrhoeae к антимикробным препаратам и средства терапии гонококковой инфекции: вчера, сегодня, завтра. Вестник дерматологии и венерологии. 2022;98(3):15–23 [Kubanov AA, Solomka VS, Rahmatulina MR, Derjabin DG. Antimicrobial resistance of Neisseria gonorrhoeae and gonococcal infection therapy: yesterday, today, tomorrow. Vestnik dermatologii i venerologii. 2022;98(3):15–23. (In Russ.)] doi: 10.25208/vdv1317
- Gonorrhoea: Annual Epidemiological Report for 2018. European Centre for Disease Prevention and Control; 2019. https://www.ecdc.europa.eu/sites/default/files/documents/gonorrhoea-annual-epidemiological-report-2018.pdf (4 June 2023).
Supplementary files
